Julia R Brown
CIK 1030468 · View on SEC EDGAR ↗
First SEC filing: Aug. 18, 2015 · Latest: Aug. 18, 2015
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2013 | GYRE | P | 6,000 | $5.09 | $30,540 | 6,000 Indirect | — | Acquired | -99.9% (price as of 2026-08-20) |
| May 13, 2011 | GYRE | S | 9,100 | $23.38 | $212,758 | 0 Direct | -100.00% | Disposed | -100.0% (price as of 2026-08-20) |
| May 21, 2010 | GYRE | S | 7,307 | $23.13 | $169,011 | 0 Direct | -100.00% | Disposed | -100.0% (price as of 2026-08-20) |
| May 20, 2010 | GYRE | S | 5,193 | $22.97 | $119,283 | 0 Direct | -100.00% | Disposed | -100.0% (price as of 2026-08-20) |
| May 12, 2010 | GYRE | S | 7,500 | $23.05 | $172,875 | 0 Direct | -100.00% | Disposed | -100.0% (price as of 2026-08-20) |
| March 17, 2009 | GYRE | P | 7,500 | $3.03 | $22,725 | 7,500 Direct | — | Acquired | -99.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 14, 2015 | GYRE | Redeemable Convertible Note | Common Stock (13,177) | $1.31 | — | — | Acquired |
| Aug. 4, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock (12,500) | $2.35 | Aug. 4, 2025 | 12,500 | Acquired |
| June 12, 2014 | GYRE | Stock Option (Right to Buy) | Common Stock (12,500) | $4.29 | June 11, 2024 | 12,500 | Acquired |
| June 7, 2013 | GYRE | Stock Option (Right to Buy) | Common Stock (12,500) | $5.23 | June 6, 2023 | 12,500 | Acquired |
| June 7, 2012 | GYRE | Stock Option (Right to Buy) | Common Stock (7,500) | $4.16 | June 6, 2022 | 7,500 | Acquired |
| June 15, 2011 | GYRE | Stock Option (Right to Buy) | Common Stock (7,500) | $21.25 | June 14, 2021 | 7,500 | Acquired |
| May 13, 2011 | GYRE | Stock Option (Right to Buy) | Common Stock (9,100) | $8.70 | Dec. 4, 2017 | 9,100 | Disposed |
| June 17, 2010 | GYRE | Stock Option (Right to Buy) | Common Stock (7,500) | $22.76 | June 16, 2020 | 7,500 | Acquired |
| May 21, 2010 | GYRE | Stock Option (Right to Buy) | Common Stock (7,307) | $8.70 | Dec. 4, 2017 | 7,307 | Acquired |
| May 20, 2010 | GYRE | Stock Option (Right to Buy) | Common Stock (5,193) | $8.70 | Dec. 4, 2017 | 5,193 | Acquired |
| June 17, 2009 | GYRE | Stock Option (Right to Buy) | Common Stock (7,500) | $2.71 | June 16, 2019 | 7,500 | Acquired |
| July 2, 2008 | GYRE | Stock Option (Right to Buy) | Common Stock (7,500) | $7.10 | July 1, 2018 | 7,500 | Acquired |
| Dec. 5, 2007 | GYRE | Stock Option (Right to Buy) | Common Stock (25,000) | $8.70 | Dec. 4, 2017 | 25,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).